3S Pharmaceutical Group

Chinese largest manufacturer of biologics.Founded in 1993, Listed in Hong Kong Stock Market with market value of USD3.7billion. National Engineering Research Center of Antibody Medicines (CMAB) and 4 integrated R&D platforms, over 300 scientists. 4 state -of-art manufacturing facilities in China and 1 in Italy Leading Core Products: TPIAO, EPIAO, YISAIPU (Etanercept), SEPO (EPO), Byetta, Bydureon, Humulin 30 commercialized products, 24 products in pipeline. Focus on oncology, autoimmune, nephrology, metabolic and dermatology therapeutic areas.Products registered and under-registration in over 40 countries.